• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Bladder cancer in 156 patients aged eighty years or more.

作者信息

Fitzpatrick J M, Durazi M, Butler M R, Lane V, O'Flynn J D

出版信息

Ir J Med Sci. 1987 Sep;156(9):259-61. doi: 10.1007/BF02954061.

DOI:10.1007/BF02954061
PMID:3679773
Abstract
摘要

相似文献

1
Bladder cancer in 156 patients aged eighty years or more.156名80岁及以上患者的膀胱癌
Ir J Med Sci. 1987 Sep;156(9):259-61. doi: 10.1007/BF02954061.
2
Patterns of recurrence in bladder cancer treated by irradiation and/or cystectomy.接受放疗和/或膀胱切除术治疗的膀胱癌复发模式。
Int J Radiat Oncol Biol Phys. 1980 Feb;6(2):155-9. doi: 10.1016/0360-3016(80)90031-0.
3
Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association.根据日本登记膀胱癌患者的数据得出的Ta、T1期非肌层浸润性膀胱癌肿瘤复发的临床结果：日本泌尿外科学会1999 - 2001年报告
Int J Urol. 2009 Mar;16(3):279-86. doi: 10.1111/j.1442-2042.2008.02235.x. Epub 2009 Jan 20.
4
Prognostic factors in superficial bladder cancer.浅表性膀胱癌的预后因素
Prog Clin Biol Res. 1986;221:257-69.
5
The results of concurrent chemo-radiotherapy for recurrence after treatment with bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: is immediate cystectomy always necessary?卡介苗治疗非肌层浸润性膀胱癌后复发的同步放化疗结果：是否总是需要立即进行膀胱切除术？
BJU Int. 2009 Jul;104(2):179-83. doi: 10.1111/j.1464-410X.2008.08299.x. Epub 2008 Dec 23.
6
Outcome after BCG treatment for urinary bladder cancer may be influenced by polymorphisms in the NOS2 and NOS3 genes.卡介苗治疗膀胱癌后的结果可能受NOS2和NOS3基因多态性的影响。
Redox Biol. 2015 Dec;6:272-277. doi: 10.1016/j.redox.2015.08.008. Epub 2015 Aug 10.
7
Is thermochemotherapy with the Synergo system a viable treatment option in patients with recurrent non-muscle-invasive bladder cancer?使用Synergo系统进行热化疗对复发性非肌层浸润性膀胱癌患者来说是一种可行的治疗选择吗？
Int J Urol. 2015 Feb;22(2):158-62. doi: 10.1111/iju.12639. Epub 2014 Oct 22.
8
Local control rate and prognosis after sequential chemoradiation for small cell carcinoma of the bladder.膀胱癌小细胞癌序贯放化疗后的局部控制率和预后。
Int J Urol. 2013 Aug;20(8):778-84. doi: 10.1111/iju.12038. Epub 2012 Dec 11.
9
[The intravesical administration of BCG vaccine in treating recurrent superficial bladder cancer].卡介苗膀胱内灌注治疗复发性浅表性膀胱癌
Urol Nefrol (Mosk). 1997 Mar-Apr(2):29-32.
10
Malpingian carcinoma of the urinary bladder: A case series.膀胱马尔平氏癌：病例系列
J Cancer Res Ther. 2015 Oct-Dec;11(4):730-4. doi: 10.4103/0973-1482.147710.

引用本文的文献

1
Superficial bladder carcinoma. Factors affecting the natural history.
World J Urol. 1993;11(3):142-7. doi: 10.1007/BF00211408.

本文引用的文献

1
Urinary diversion in the elderly patient.老年患者的尿路改道
Eur Urol. 1980;6(6):347-51. doi: 10.1159/000473370.
2
Cystectomy and urinary diversion in patients eighty years old or older.80岁及以上患者的膀胱切除术和尿流改道术。
Urology. 1982 Feb;19(2):139-42. doi: 10.1016/0090-4295(82)90567-2.
3
Radical cystectomy in the elderly patient.
J Urol. 1984 Jun;131(6):1065-8. doi: 10.1016/s0022-5347(17)50808-3.
4
Smoking and health. The facts in Ireland.
Ir Med J. 1983 Dec;76(12 Suppl):1-29.
5
Treatment of bladder carcinoma in patients more than 80 years old.80岁以上膀胱癌患者的治疗
J Urol. 1985 Nov;134(5):889-91. doi: 10.1016/s0022-5347(17)47510-0.
6
Superficial bladder tumors (stage pTa, grades 1 and 2): the importance of recurrence pattern following initial resection.
J Urol. 1986 May;135(5):920-2. doi: 10.1016/s0022-5347(17)45923-4.
7
Bladder carcinoma in patients 40 years old or less.
J Urol. 1986 Jan;135(1):53-4. doi: 10.1016/s0022-5347(17)45513-3.
8
Is cystectomy a safe procedure in elderly patients with carcinoma of the bladder?膀胱切除术对老年膀胱癌患者来说是一种安全的手术吗？
J Urol. 1977 Jul;118(1 Pt 1):40-2. doi: 10.1016/s0022-5347(17)57879-9.